JP2023531567A5 - - Google Patents

Info

Publication number
JP2023531567A5
JP2023531567A5 JP2023523315A JP2023523315A JP2023531567A5 JP 2023531567 A5 JP2023531567 A5 JP 2023531567A5 JP 2023523315 A JP2023523315 A JP 2023523315A JP 2023523315 A JP2023523315 A JP 2023523315A JP 2023531567 A5 JP2023531567 A5 JP 2023531567A5
Authority
JP
Japan
Prior art keywords
subject
subjects
test
test substance
progressive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023523315A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023531567A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2021/050705 external-priority patent/WO2022000041A1/en
Publication of JP2023531567A publication Critical patent/JP2023531567A/ja
Publication of JP2023531567A5 publication Critical patent/JP2023531567A5/ja
Pending legal-status Critical Current

Links

JP2023523315A 2020-06-30 2021-06-30 進行性前立腺がんを判定するためのバイオマーカー組合せ Pending JP2023531567A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020902212A AU2020902212A0 (en) 2020-06-30 Biomarker combinations for determining aggressive prostate cancer
AU2020902212 2020-06-30
PCT/AU2021/050705 WO2022000041A1 (en) 2020-06-30 2021-06-30 Biomarker combinations for determining aggressive prostate cancer

Publications (2)

Publication Number Publication Date
JP2023531567A JP2023531567A (ja) 2023-07-24
JP2023531567A5 true JP2023531567A5 (https=) 2024-07-08

Family

ID=79317588

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023523315A Pending JP2023531567A (ja) 2020-06-30 2021-06-30 進行性前立腺がんを判定するためのバイオマーカー組合せ

Country Status (6)

Country Link
US (1) US20230305009A1 (https=)
EP (1) EP4172629A4 (https=)
JP (1) JP2023531567A (https=)
AU (1) AU2021298661A1 (https=)
CA (1) CA3188184A1 (https=)
WO (1) WO2022000041A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4605753A1 (en) * 2022-10-20 2025-08-27 Minomic International Ltd. Methods for detecting aggressive prostate cancer
CN121101470A (zh) * 2025-09-08 2025-12-12 简勇 一种癌症危险程度辨别方法和系统

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019352906B2 (en) * 2018-10-05 2026-01-22 Minomic International Ltd. Biomarker combinations for determining aggressive prostate cancer

Similar Documents

Publication Publication Date Title
TWI698639B (zh) 前列腺抗原標準品及其用途
JP5911092B2 (ja) 妊娠検査具
CN113439212B (zh) 用于确定侵袭性前列腺癌的生物标志物组合
JP2023531567A5 (https=)
CN116660537A (zh) 一种评估三阴乳腺癌复发和预后的生物标志物及其应用
JP4272066B2 (ja) Ｃａ１９−９の測定による敗血症の検出方法
JP6760666B2 (ja) 前立腺疾患のためのバイオマーカーの組み合わせ
Mateo et al. Development and evaluation of a rapid and sensitive homogeneous assay for haptoglobin measurements in saliva
JP2023531567A (ja) 進行性前立腺がんを判定するためのバイオマーカー組合せ
KR102047989B1 (ko) 급성 열성 질환을 진단하기 위한 현장 진단 시스템 및 방법
CN114814243B (zh) 应用于蛋白质抗原的定量检测试剂盒及方法
WO2019224755A1 (en) Biomarkers for diagnosing tuberculous meningitis
CN109324192A (zh) 快速定量检测抗核抗体含量的检测方法
CN119630966A (zh) 用于对膀胱癌进行风险分层和管理的方法和系统
CN116068203A (zh) Ddx5在制备诊断或检测系统性红斑狼疮试剂盒中的应用
CN204287198U (zh) 全程c-反应蛋白免疫层析定量检测试纸条
CN119876392B (zh) 一种用于辅助诊断肺腺癌骨转移的生物标志物
CN217820411U (zh) 一种脑卒中五项联合检测卡
CN113125751B (zh) 外周血pd-1/pd-l1预测乳腺癌肿瘤组织中pd-l1水平的方法
CN119023963A (zh) 一种新的肝癌标志物impdh2及其应用
EP3495821B1 (en) Diagnostic method for determining nox2 protein
CN110678754A (zh) 基于唾液白介素-1β以及肝细胞生长因子的牙龈炎的诊断
Yildizhan et al. FO-SPR bioassay development for specific and sensitive analysis of extracellular vesicles
Alanazi et al. Laboratory Diagnostic Testing of Inflammatory Biomarkers: Laboratory Approaches in Chronic Heart Failure
Blanchard et al. A solid-phase fluoroimmunoassay for human IgE